Skip to Content

CryoPort Inc CYRX Stock Quote

| Rating as of

NASDAQ:CYRX

Morningstar‘s Stock Analysis CYRX

Valuation
Currency in USD
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price

INVESTOR

5-Star Price

INVESTOR

Economic Moat

INVESTOR

About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Key Statistics CYRX

Company Profile CYRX

Business Description

CryoPort Inc is a provider of a temperature-controlled supply chain for the life sciences industry by providing an evolving platform of critical products and solutions including advanced packaging, informatics, specialty logistics services, biostorage services, and cryogenic life sciences equipment. The company provides global solutions to the biopharma/pharma, animal health, and human reproductive medicine markets. Its primary focus is on addressing the critical temperature-controlled supply chain needs within the biopharmaceutical space with an emphasis on serving the rapidly growing cell and gene therapy market.

Contact
112 Westwood Place, Suite 350
Brentwood, TN, 37027
T +1 949 470-2300
Industry Integrated Freight & Logistics
Most Recent Earnings Sep 30, 2022
Fiscal Year End Dec 31, 2022
Employees 900